Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hepsulfam is an anticancer agent. It also displays excellent antileukemic activity (a median IC50: 0.91 μg/mL in a panel of different tumors).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 140.00 | |
25 mg | 6-8 weeks | $ 766.00 | |
50 mg | 6-8 weeks | $ 996.00 | |
100 mg | 6-8 weeks | $ 1,540.00 | |
1 mL * 10 mM (in DMSO) | 5 days | $ 316.00 |
Description | Hepsulfam is an anticancer agent. It also displays excellent antileukemic activity (a median IC50: 0.91 μg/mL in a panel of different tumors). |
Targets&IC50 | Tumors:0.91 μg/ml |
In vitro | Hepsulfam exhibits greater toxicity towards L1210 leukemia cells compared to busulfan, its structural analogue, by inducing DNA interstrand cross-links in these cells, an effect not seen with busulfan. This compound also shows increased cytotoxicity against human leukemia (111-60 and K562) and colon carcinoma (BE and HT-29) cell lines relative to busulfan, correlating with higher levels of DNA interstrand cross-links. In a clonogenic assay, hepsulfam demonstrated activity in 22% (8 out of 37) of tumors at a concentration of 1.0 μg/mL. Additionally, it significantly affects human bone marrow cells (CFU-GM) from healthy donors, indicating its potency. In vitro evaluations reveal hepsulfam's superior activity, notably against non-small cell lung cancer, even at tenfold reduced concentrations and extended exposure times (12 h), underscoring its potential therapeutic benefit in a broad spectrum of cancers. |
In vivo | The preclinical activity of hepsulfam shows a possible role of this compound in the treatment of solid human malignancies. Hepsulfam demonstrates superior in vivo activity in a large cell lung cancer xenograft and a gastric carcinoma model. The increased bone marrow toxicity of hepsulfam as compared with the busulfan might be critical for further clinical application[1]. |
Synonyms | NCI 329680, ZINC01574758 |
Molecular Weight | 290.36 |
Formula | C7H18N2O6S2 |
CAS No. | 96892-57-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Hepsulfam 96892-57-8 Others NCI 329680 ZINC-01574758 ZINC01574758 ZINC 01574758 NCI329680 NCI-329680 inhibitor inhibit